, Agreement on mutual recognition between the European Community and the United States of…

In forcesince 1 Mar 2017
1.

Member State authorities for human pharmaceuticals listed in Appendix 2 shall submit complete capability assessment packages containing the information specified in paragraph II.A.1 of Appendix 4 according to the following schedule:

No later than January 1, 2017: capability assessment packages from four Member State authorities

No later than February 15, 2017: capability assessment packages from three additional Member State authorities

No later than April 1, 2017: capability assessment packages from two additional Member State authorities.

No later than May 15, 2017: capability assessment packages from two additional Member State authorities

No later than September 15, 2017: capability assessment packages from two additional Member State authorities

No later than December 15, 2017: capability assessment packages from four additional Member State authorities

No later than March 15, 2018: capability assessment packages from four additional Member State authorities

No later than June 15, 2018: capability assessment packages from seven additional Member State authorities

2.

The FDA shall complete assessments under this Annex of Member State authorities for human pharmaceuticals listed in Appendix 2 as set out in paragraph II.A.4 and according to the following schedule, provided that the FDA receives complete capability assessment packages for such authorities containing the information specified in paragraph II.A.1 of Appendix 4 according to the schedule set out in paragraph 1:

November 1, 2017: eight assessments

March 1, 2018: four additional assessments

June 1, 2018: two additional assessments

December 1, 2018: six additional assessments

July 15, 2019: eight additional assessments

3.

For each Member State authority:

(a)

The EU shall submit a final audit report to the FDA no later than 60 days before the due date of the capability assessment package for the authority.

(b)

The FDA shall provide a finalized capability assessment package checklist to the authority no later than 20 days after the FDA receives the audit report.

(c)

The authority shall submit the capability assessment package to FDA no later than 40 days after the authority receives the capability assessment package checklist.